EXAGEN INC. — Director's Dealing 2019

Sep 18, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2019-09-18

Reporting Person: PALLARES EBETUEL (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	179	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$688.63		Common Stock (199)		Indirect
Warrants	$1.84		Common Stock (22427)		Indirect
Warrants	$1.84		Common Stock (2265)		Indirect
Warrants	$14.3235		Series E Redeemable Convertible Preferred Stock (219978)		Indirect
Series E Redeemable Convertible Preferred Stock	$		Common Stock (77204)		Indirect
Series F Redeemable Convertible Preferred Stock	$		Common Stock (43405)		Indirect

Footnotes

F1: The shares reported on this form are held of record by PCM/Exagen, L.P. ("PCM"). Ebetuel Pallares is a co-manager of PCM. As a result, each of PCM and Dr. Pallares may be deemed to share beneficial ownership of the shares held of record by PCM.

F2: The warrants are currently exercisable and will terminate upon closing of the Issuer's initial public offering.

F3: The warrants are currently exercisable and will expire on January 19, 2026.

F4: The warrants are currently exercisable and will expire on March 31, 2026.

F5: The Series E Redeemable Convertible Preferred Stock (the "Series E") is convertible into the Issuer's Common Stock on a 57.294-for-one basis at the holder's election and has no expiration date. The Series E will automatically convert into Commons Stock upon the closing of the Issuer's initial public offering.

F6: The Series F Redeemable Convertible Preferred Stock ("Series F") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series F will automatically convert into Commons Stock upon the closing of the Issuer's initial public offering.